ATE338058T1 - Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen - Google Patents

Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen

Info

Publication number: ATE338058T1
Authority: AT; Austria
Prior art keywords: perindopril; synthesis; pharmaceutically acceptable; acceptable salts; salts
Prior art date: 2003-07-31

Application number

AT03291930T

Other languages

English (en)

Inventor

Claude Fugier

Thierry Dubuffet

Pascal Langlois

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-31

Filing date

2003-07-31

Publication date

2006-09-15

2003-07-31 Application filed by Servier Lab filed Critical Servier Lab

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE338058T1 publication Critical patent/ATE338058T1/de

Links

230000015572 biosynthetic process Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
229960002582 perindopril Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hospice & Palliative Care (AREA)
Indole Compounds (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

AT03291930T 2003-07-31 2003-07-31 Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen ATE338058T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03291930A EP1367062B1 (de)	2003-07-31	2003-07-31	Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen

Publications (1)

Publication Number	Publication Date
ATE338058T1 true ATE338058T1 (de)	2006-09-15

Family

ID=29414889

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03291930T ATE338058T1 (de)	2003-07-31	2003-07-31	Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen

Country Status (19)

Country	Link
US (1)	US7368580B2 (de)
EP (1)	EP1367062B1 (de)
JP (1)	JP4263744B2 (de)
CN (1)	CN100439392C (de)
AR (1)	AR045150A1 (de)
AT (1)	ATE338058T1 (de)
AU (1)	AU2004261440B2 (de)
CY (1)	CY1105789T1 (de)
DE (1)	DE60307925T2 (de)
DK (1)	DK1367062T3 (de)
EA (1)	EA008644B1 (de)
ES (1)	ES2271497T3 (de)
MY (1)	MY139098A (de)
NZ (1)	NZ544880A (de)
PL (1)	PL211802B1 (de)
PT (1)	PT1367062E (de)
SI (1)	SI1367062T1 (de)
WO (1)	WO2005012328A2 (de)
ZA (1)	ZA200600480B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI21800A (sl) *	2004-05-14	2005-12-31	Krka, Tovarna Zdravil, D.D., Novo Mesto	Nov postopek sinteze perindoprila
WO2016178591A2 (en)	2015-05-05	2016-11-10	Gene Predit, Sa	Genetic markers and treatment of male obesity
PH12018502155B1 (en)	2016-04-20	2024-03-27	Servier Lab	Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES8604144A1 (es) *	1984-11-21	1986-01-16	Farmhispania	Procedimiento para la obtencion del acido (2s, 3as, 7as)-1-((s)-1-etoxicarbonil-3-fenilpropil) alanil) exahidro-2-indolincarboxilico
FR2807431B1 (fr) *	2000-04-06	2002-07-19	Adir	Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
ES2240919T3 (es) *	2003-03-12	2005-10-16	Les Laboratoires Servier	Nuevo procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables.
PT1319668E (pt) *	2003-03-12	2005-02-28	Servier Lab	Novo processo de sintese de derivados do acido (2s,3as,7as)-1-[(s)-alanil]-octa-hidro-1h-indole-2-carboxilico e aplicacao a sintese de perindopril

2003
- 2003-07-31 DE DE60307925T patent/DE60307925T2/de not_active Expired - Lifetime
- 2003-07-31 PT PT03291930T patent/PT1367062E/pt unknown
- 2003-07-31 EP EP03291930A patent/EP1367062B1/de not_active Expired - Lifetime
- 2003-07-31 DK DK03291930T patent/DK1367062T3/da active
- 2003-07-31 AT AT03291930T patent/ATE338058T1/de active
- 2003-07-31 ES ES03291930T patent/ES2271497T3/es not_active Expired - Lifetime
- 2003-07-31 SI SI200330449T patent/SI1367062T1/sl unknown
2004
- 2004-07-29 PL PL379625A patent/PL211802B1/pl unknown
- 2004-07-29 AR ARP040102692A patent/AR045150A1/es not_active Application Discontinuation
- 2004-07-29 JP JP2006521622A patent/JP4263744B2/ja not_active Expired - Fee Related
- 2004-07-29 MY MYPI20043052A patent/MY139098A/en unknown
- 2004-07-29 WO PCT/FR2004/002036 patent/WO2005012328A2/fr not_active Ceased
- 2004-07-29 CN CNB2004800212086A patent/CN100439392C/zh not_active Expired - Fee Related
- 2004-07-29 NZ NZ544880A patent/NZ544880A/en not_active IP Right Cessation
- 2004-07-29 AU AU2004261440A patent/AU2004261440B2/en not_active Ceased
- 2004-07-29 US US10/566,558 patent/US7368580B2/en not_active Expired - Fee Related
- 2004-07-29 ZA ZA200600480A patent/ZA200600480B/en unknown
- 2004-07-29 EA EA200600249A patent/EA008644B1/ru not_active IP Right Cessation
2006
- 2006-11-16 CY CY20061101671T patent/CY1105789T1/el unknown

Also Published As

Publication number	Publication date
HK1096407A1 (zh)	2007-06-01
ZA200600480B (en)	2007-05-30
PT1367062E (pt)	2006-12-29
JP4263744B2 (ja)	2009-05-13
EP1367062B1 (de)	2006-08-30
EA200600249A1 (ru)	2006-06-30
AU2004261440B2 (en)	2008-07-31
CY1105789T1 (el)	2011-02-02
PL379625A1 (pl)	2006-10-30
DE60307925D1 (de)	2006-10-12
PL211802B1 (pl)	2012-06-29
WO2005012328A3 (fr)	2005-03-24
DE60307925T2 (de)	2007-05-24
ES2271497T3 (es)	2007-04-16
US7368580B2 (en)	2008-05-06
DK1367062T3 (da)	2007-01-02
CN1826351A (zh)	2006-08-30
NZ544880A (en)	2009-03-31
WO2005012328A2 (fr)	2005-02-10
US20060189813A1 (en)	2006-08-24
SI1367062T1 (sl)	2006-12-31
MY139098A (en)	2009-08-28
JP2006528653A (ja)	2006-12-21
EA008644B1 (ru)	2007-06-29
CN100439392C (zh)	2008-12-03
AU2004261440A1 (en)	2005-02-10
EP1367062A1 (de)	2003-12-03
AR045150A1 (es)	2005-10-19

Legal Events

Date

Code

Title

Description

2007-04-15

UEP

Publication of translation of european patent specification

Ref document number: 1367062

Country of ref document: EP

Publication	Publication Date	Title
ATE369338T1 (de)	2007-08-15	Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze
EP1569618A4 (de)	2009-12-30	Verfahren und zusammensetzungen für die verabreichung von pharmakologischen mitteln an das ohr
EP1680109A4 (de)	2009-05-06	Amid-derivate als ionenkanal-liganden und pharmazeutische zusammensetzungen und anwendungsverfahren
ATE315043T1 (de)	2006-02-15	Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
ATE354586T1 (de)	2007-03-15	Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
ATE360638T1 (de)	2007-05-15	Verfahren für die synthese von perindopril und seiner pharmazeutisch geeigneten salze
ATE365714T1 (de)	2007-07-15	Verfahren zur herstellung von hochreinem perindopril und zwischenverbindungen nützlich in der synthese
ATE294814T1 (de)	2005-05-15	Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
ATE306496T1 (de)	2005-10-15	Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
ATE338766T1 (de)	2006-09-15	Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen
EG24152A (en)	2008-08-19	Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
ATE386745T1 (de)	2008-03-15	Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen
ATE310012T1 (de)	2005-12-15	Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen
ATE307139T1 (de)	2005-11-15	Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salze
ATE337332T1 (de)	2006-09-15	Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
ATE338058T1 (de)	2006-09-15	Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
ATE353910T1 (de)	2007-03-15	Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen
DE60336931D1 (de)	2011-06-09	Verfahren zur synthese der bisbenzimidazolen und ihren derivaten.
ATE534624T1 (de)	2011-12-15	Verfahren und zwischenprodukte für die herstellung von n-(1-benzhydryl-azetidin-3-yl)-n- phenyl-methylsulphonamid-derivaten